Company news
Dong-a St Co., Ltd. (KRX:170900) news
Dong-a St Co., Ltd. news releases on 6ix. Latest, Mar 12, 2026: MetaVia Expands Global Patent Protection for Vanoglipel, Supporting Metabolic and Liver…
Press releases & updates
MetaVia Expands Global Patent Protection for Vanoglipel, Supporting Metabolic and Liver Disease Therapy Through 2035
March 12, 2026
MetaVia Builds Comprehensive Global Patent Protection for DA-1726, Securing Exclusive Rights to Novel Obesity and Metabolic Therapy Through 2041
February 13, 2026
XtalPi Signs MOU with Dong-A ST for Joint Research and Development of Immunology and Inflammation Therapies
August 19, 2025
Dong-A ST’s IMULDOSA™ (ustekinumab-srlf), a Biosimilar to STELARA®, receives approval from US FDA
October 14, 2024
Dong-A ST Out License NESP® Biosimilar DA-3880 to Polifarma of Türkiye
November 9, 2022